Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as GBX 24 ($0.32) and last traded at GBX 24 ($0.32), with a volume of 433847 shares trading hands. The stock had previously closed at GBX 26.68 ($0.36).
Creo Medical Group Stock Down 3.0 %
The firm has a market capitalization of £76.53 million, a price-to-earnings ratio of -352.58 and a beta of 0.86. The company has a debt-to-equity ratio of 13.88, a quick ratio of 2.19 and a current ratio of 3.83. The business’s 50 day moving average is GBX 28.94 and its 200-day moving average is GBX 32.83.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Recommended Stories
- Five stocks we like better than Creo Medical Group
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- ESG Stocks, What Investors Should Know
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- What is a Stock Market Index and How Do You Use Them?
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
-pt-telekomunikasi-indonesia-tbk-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}